UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway Journal article
Xu, Nan, Luo, Huijuan, Li, Minyao, Wu, Jiazhen, Wu, Xue, Chen, Liping, Gan, Yuxuan, Guan, Fengkun, Li, Mengyao, Su, Ziren, Chen, Jiannan, Liu, Yuhong. β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway[J]. Biomedicine and Pharmacotherapy, 2021, 134.
Authors:  Xu, Nan;  Luo, Huijuan;  Li, Minyao;  Wu, Jiazhen;  Wu, Xue; et al.
Favorite | TC[WOS]:18 TC[Scopus]:20  IF:6.9/6.8 | Submit date:2021/12/07
Amp-activated Protein Kinase  Hepatic Steatosis  Non-alcoholic Fatty Liver Disease  Pogostemon Cablin  Β-patchoulene  
The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats Journal article
Lin Z., Wu Z.-F., Jiang C.-H., Zhang Q.-W., Ouyang S., Che C.-T., Zhang J., Yin Z.-Q.. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats[J]. Phytomedicine, 2016, 23(12), 1475-1483.
Authors:  Lin Z.;  Wu Z.-F.;  Jiang C.-H.;  Zhang Q.-W.;  Ouyang S.; et al.
Favorite | TC[WOS]:43 TC[Scopus]:46  IF:6.7/6.2 | Submit date:2018/12/28
Cyclocarya Paliurus  Hepatic Steatosis  Lipogenesis  Non-alcoholic Fatty Liver Disease  Proton Magnetic Resonance Spectrum  
Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis Journal article
Xiang M., Wang P.-X., Wang A.-B., Zhang X.-J., Zhang Y., Zhang P., Mei F.-H., Chen M.-H., Li H.. Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis[J]. Journal of Hepatology, 2016, 64(6), 1365.
Authors:  Xiang M.;  Wang P.-X.;  Wang A.-B.;  Zhang X.-J.;  Zhang Y.; et al.
Favorite | TC[WOS]:105 TC[Scopus]:117 | Submit date:2018/10/30
Ask1  Hepatic Steatosis  Inflammation  Insulin Resistance  Traf1  
Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines Journal article
Huang L.-L., Wan J.-B., Wang B., He C.-W., Ma H., Li T.-W., Kang J.X.. Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines[J]. Prostaglandins Leukotrienes and Essential Fatty Acids, 2013, 88(5), 347-353.
Authors:  Huang L.-L.;  Wan J.-B.;  Wang B.;  He C.-W.;  Ma H.; et al.
Favorite | TC[WOS]:62 TC[Scopus]:67  IF:2.9/3.2 | Submit date:2018/10/30
Alcoholic Liver Disease  Hepatic Steatosis  Docosahexaenoic Acid  Stearoyl-coa Desaturase 1  Inflammatory Cytokines